Der opiatentzug in narkose (forcierter narkoseentzug, "turboentzug") bei opiatabhängigkeit: Entzugsbehandlungen im wandel der zeit - wunsch und wirklichkeit

Nervenarzt

Volumn 67, Issue 9, 1996, Pages 805-810

  Dettling, M ^a   Tretter, F ^b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b KLINIKUM MÜNCHEN OST   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; METHADONE; NALOXONE; NARCOTIC ANTAGONIST; NALTREXONE; OPIATE;

ADULT; ANIMAL; ARTICLE; FEMALE; GENERAL ANESTHESIA; HEROIN DEPENDENCE; HUMAN; MALE; PILOT STUDY; TREATMENT OUTCOME; WITHDRAWAL SYNDROME; ANESTHESIA; DRUG DEPENDENCE; DRUG WITHDRAWAL; SHORT SURVEY;

ADULT; ANESTHESIA, GENERAL; ANIMALS; CODEINE; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; METHADONE; NALOXONE; NARCOTIC ANTAGONISTS; PILOT PROJECTS; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME;

EID: 0029767862     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050058     Document Type: Article

References (34)

1. Allbutt C (1870) On the abuse of hypodermic injections of morphine. Practitioner 3: 327
2. Bigelow GE, Preston KL (1995) Opioids. In: Bloom F, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven, Press, New York, pp 1731-1744
3. Blachly RH, Casey D, Marcel L (1975) Rapid detoxification from heroin and methadone maintenance using naloxone. A model for study of the treatment of the opiate abstinence syndrome. In: Senay E, Shorty V, Alkesne H (eds) Developments in the field of drug abuse. Schenkman, Cambridge
4. Brewer C, Rezae H, Bailey C (1988) Opioid withdrawal and naltrexone induction in 48-72 hours with minimal drop-out, using a modification of the naltrexone-clonidine technique. Br J Psychiatry 153: 340-343
5. Charney, DS, Riordan CE, Kleber HD, Murburg M, Braverman P, Sternberg DE, Heninger GR, Redmond E (1982) Clonidine and Naltrexone. Arch Gen Psychiatry 39: 1327-1332
6. Charney DS, Redmond E, Galloway MP, Kleber HD, Heninger GR, Murberg M, Roth RH (1984) Naltrexone precipitated opiate withdrawal in methadone addicted patients: evidence for noradrenergic hyperactivity. Life Sci 35: 1263-1272
7. Charney DS, Heninger GR, Kleber HD (1986) The combined use of clonidine and naltrexone as a rapid, safe, and effective treatment of abrupt withdrawal from methadone. Am J Psychiatry 143: 831-837
8. Eisenberg RM (1985) Effects of chronic treatment with diazepam, phenobarbital or amphetamine on naloxone-precipitated morphine withdrawal. Drug Alcohol Depend 15: 175-181
9. Fraser HF, Isbell H (1956) Chlorpromazine and reserpine. (a) Effects of each and of combinations of each with morphine, (b) Failure of each in treatment of abstinence from morphine. Arch Neurol Psychiatry 76: 257-262
10. Friedgood CE, Ripstein CB (1955) Use of chlorpromazine in the withdrawal of addicting drugs. N Engl J Med 252: 230-233
11. Haertzen CA, Meketon MJ (1968) Opiate withdrawal is measured by the Addiction Research Center Inventory (ARCI). Dis Nerv Syst 29: 450-455
12. Hendrie CA (1985) Opiate dependence and withdrawal-a new synthesis? Pharmacol Biochem Behav 23: 863-870
13. Herz A (1995) Neurobiologische Grundlagen des Suchtgeschehens. Nervenarzt 66: 3-14
14. Holman PW (1985) Clonidine and naloxone in ultrashort opiate detoxification. Clin Pharmacol 4: 100-102
15. Isbell H, Vogel VH (1948) The addiction liability of methadone and its use in the treatment of the morphine abstinence syndrome. Am J Psychiatry 105: 909-914
16. Kleber HD, Riordan CE (1982) The treatment of narcotic withdrawal: a historical review. J Clin Psychiatry 43: 30-34
17. Kolb L, Himmelsbach CK (1938) Clinial studies of drug addiction. III. A critical review of the withdrawal treatment with method of evaluating abstinence syndromes. Am J Psychiatry 94: 759-799
18. Kramer JC (1977) Heroin in the treatment of morphine addiction. J Psychedel Drugs 9: 193-197
19. Ladewig D, Stohler R (1994) Das Opiatentzugssyndrom: Skalierungen und medikamentöse Strategien. In: Tretter F, Bussello-Spieth S, Bender W (Hrsg) Therapie von Entzugssyndromen, Springer, Berlin Heidelberg New York, S 145-157
20. Legarda JJ, Gossop M (1994) A 24-h inpatient detoxification treatment for heroin addicts: a preliminary investigation. Drug Alcohol Depend 35: 91-93
21. Loimer N, Schmid RW, Presslich O, Lenz K (1989) Continuous naloxone administration suppresses opiate withdrawal symptoms in human opiate addicts during detoxification treatment. J Psychiatr Res 23: 81-86
22. Loimer N, Schmid R, Lenz K, Presslich O, Grünberger J (1990) Acute blocking of naloxone-precipitated opiate withdrawal symptoms by methohexitone. Br J Psychiatry 157: 748-752
23. Loimer N, Linzmayer L, Grünberger J (1991) Comparison between observer assessment and self rating of withdrawal distress during opiate detoxification. Drug Alcohol Depend 28: 265-268
24. Loimer N, Lenz K, Schmidt R, Presslich O (1991) Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates. Am J Psychiatry 148: 933-935
25. Masini E, Blandina P, Mannaioni PF (1981) Clonidin and naloxone for rapid opiate detoxification: comparison between treatments. Toxicology 18: 1021-1026
26. Newman MK, Berris JM (1941) Artificial hibernation therapy. Arch Physiol Ther 22: 161-167
27. Nyswander M (1956) The drug addict as a patient. Grune & Stratton, New York
28. Resnick RB, Kestenbaum RS, Washton A, Poole D (1976) Naloxone-precipitated withdrawal. A method for rapid induction onto naltrexone. Clin Pharmacol Ther 21: 409-413
29. Riordan CE, Kleber HD (1980) Rapid opiate detoxification with clonidine and naloxone. Lancet I (8177): 1079-1080
30. Sakel M (1935) das Wesen und die Entstehung der Hypoglykämiebchandlung der Psychosen. Schweiz Arch Neurol Psychiatry 39: 21-32
31. Thigpen FB, Thigpen CH, Cleckley HM (1953) The use of electroconvulsive therapy in morphine, meperidine, and related alkaloid addictions. Arch Neurol Psychiatry 70: 452-458
32. Tretter F (1996) Von der Phantasie, die Sucht auszuschlafen. Münch Med Wochenschr 138: 76-77
33. Wang RIH, Wiesen RL, Lamid S, Roh BL (1974) Rating the presence and severity of opiate dependence. Clin Pharmacol Ther 16: 653-658
34. Wikler A, Fraser HF, Isbell H (1953) Nallynylmorphine: effects of single doses and precipitation of "acute abstinence syndromes" during addiction to morphine, methadone or heroin in man (post-addicts). J Pharmacol Exp Ther 109: 8-20